Latest Asx News

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

FSI’s FY2025 portfolio posted a modest 5.0% return, trailing the ASX All Ordinaries Index, while maintaining dividend growth and planning a strategic move into pre-IPO investments.

James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.

Arafura Rare Earths Limited has announced a Share Purchase Plan (SPP) targeting $50 million to support its Nolans Project, subject to shareholder approval. The offer allows eligible shareholders to subscribe for shares at a discounted price, with potential oversubscriptions up to $20 million.

Aeris Resources has launched a Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy shares at a discounted price, aiming to raise up to $10 million for working capital.

Clean TeQ Water has landed a significant A$19.2 million contract with Rio Tinto’s subsidiary for the Rincon Lithium Project in Argentina, marking its first major South American venture and a milestone in lithium refining technology.

Latrobe Magnesium Limited has successfully closed its non-renounceable entitlement offer, raising approximately $4 million with Shaw Partners underwriting the shortfall. The new shares are set to begin trading on the ASX on 12 November 2025.

Group 6 Metals has materially improved its debt position by converting warrants under its April 2025 recapitalisation plan, signaling renewed shareholder confidence and operational momentum.

Finaccess Restauración, S.L. has secured acceptances exceeding 90% in its takeover bid for Restaurant Brands New Zealand, setting the stage for compulsory acquisition of remaining shares and imminent delisting.

Greenvale Energy Ltd has had its trading suspension lifted immediately following the release of a capital raise announcement, signaling renewed market activity for the energy company.

Greenvale Energy has raised approximately $1.05 million through a share placement to fund ongoing uranium exploration at its Oasis project, with a Security Purchase Plan also offered to shareholders.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.